For research use only
| Cat No. | ABC-RC005Y |
| Product Type | Reporter Stable Cell Lines |
| Cell Type | Epithelial |
| Species | Mouse |
| Host Cell | KLN205 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Storage | Liquid Nitrogen |
KLN205/RFP-Luciferase Stable Cell Line by AcceGen combines red fluorescence and bioluminescence for dual-mode tumor tracking in cancer research studies.
KLN205/RFP-Luciferase Stable Cell Line is a dual-reporter murine lung squamous carcinoma model engineered from KLN205 cells through stable co-expression of red fluorescent protein (RFP) and luciferase. This line retains the epithelial morphology and tumorigenic properties of parental KLN205 cells while offering dual-modal imaging: RFP for real-time fluorescence tracking in vitro and luciferase for sensitive bioluminescence detection in vivo. The stable expression of both reporters enables longitudinal monitoring of tumor growth, metastasis, and therapeutic response in preclinical studies. This dual-reporter system supports diverse applications including drug screening, metastasis research, tumor microenvironment analysis, and treatment efficacy evaluation, while allowing cross-validation of experimental results. Rigorous quality control confirms all cells are free of mycoplasma, fungi, yeast, and bacteria.
| Species | Mouse |
| Cat.No | ABC-RC005Y |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Biosafety Level | 2 |
| Storage | Liquid Nitrogen |
| Product Type | Reporter Stable Cell Lines |
| Host Cell | KLN205 |
| Gene Info | RFP / Luciferase |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The KLN205/RFP-Luciferase Stable Cell Line combines RFP fluorescence and luciferase bioluminescence to provide dual-mode imaging for advanced cancer research. RFP enables cellular-level visualization in vitro, while luciferase supports sensitive, non-invasive in vivo tracking of tumor growth and metastasis. This dual-modality system is particularly useful for longitudinal studies of therapeutic response in murine lung squamous carcinoma models, offering complementary imaging data for quantitative analysis in drug screening, metastasis studies, and treatment evaluation.